We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARC
1726
DELISTED
ARC Document Solutions, Inc.
ARC
$28K ﹤0.01%
20,265
-16,392
-45% -$21.4K
ASRT
1727
DELISTED
Assertio
ASRT
$27K ﹤0.01%
353
+300
+566% +$17.6K
BST icon
1728
BlackRock Science and Technology Trust
BST
$1.69B
$27K ﹤0.01%
+826
New +$26.8K
CXW icon
1729
CoreCivic
CXW
$3.19B
$27K ﹤0.01%
1,531
+105
+7% +$1.66K
ELP
1730
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$27K ﹤0.01%
4,008
-557
-12% -$3.15K
EWK icon
1731
iShares MSCI Belgium ETF
EWK
$165M
$27K ﹤0.01%
1,331
-357
-21% -$6.91K
EXTR icon
1732
Extreme Networks
EXTR
$3.15B
$27K ﹤0.01%
3,682
+3,427
+1,344% +$24K
FAZ
1733
Direxion Daily Financial Bear 3x ETF
FAZ
$86.7M
$27K ﹤0.01%
12
+8
+200% +$20.2K
FONR
1734
DELISTED
Fonar
FONR
$27K ﹤0.01%
1,337
-3,106
-70% -$62.2K
GOSS icon
1735
Gossamer Bio
GOSS
$87M
$27K ﹤0.01%
1,708
-12,554
-88% -$253K
IOSP icon
1736
Innospec
IOSP
$2.28B
$27K ﹤0.01%
260
+101
+64% +$9.66K
NGVT icon
1737
Ingevity
NGVT
$2.68B
$27K ﹤0.01%
309
-2,548
-89% -$223K
PAHC icon
1738
Phibro Animal Health
PAHC
$1.39B
$27K ﹤0.01%
+1,103
New +$25.6K
URBN icon
1739
Urban Outfitters
URBN
$6.59B
$27K ﹤0.01%
979
+427
+77% +$11.9K
WWW icon
1740
Wolverine World Wide
WWW
$1.55B
$27K ﹤0.01%
801
-3,259
-80% -$102K
XHB icon
1741
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
$27K ﹤0.01%
+600
New +$27.1K
ARQ icon
1742
Arq
ARQ
$89.3M
$27K ﹤0.01%
2,592
+1,605
+163% +$19.2K
ENZ
1743
DELISTED
Enzo Biochem, Inc.
ENZ
$27K ﹤0.01%
10,301
+10,140
+6,298% +$30.3K
AXNX
1744
DELISTED
Axonics, Inc. Common Stock
AXNX
$27K ﹤0.01%
965
+69
+8% +$1.65K
BKI
1745
DELISTED
Black Knight, Inc. Common Stock
BKI
$27K ﹤0.01%
425
-730
-63% -$45.2K
FRC
1746
DELISTED
First Republic Bank
FRC
$27K ﹤0.01%
233
-3,247
-93% -$351K
ABMD
1747
DELISTED
Abiomed Inc
ABMD
$27K ﹤0.01%
160
-2,427
-94% -$450K
UROV
1748
DELISTED
Urovant Sciences Ltd.
UROV
$27K ﹤0.01%
+1,735
New +$18.8K
NEOS
1749
DELISTED
Neos Therapeutics, Inc
NEOS
$27K ﹤0.01%
17,864
+4,302
+32% +$6.45K
PFNX
1750
DELISTED
Pfenex Inc.
PFNX
$27K ﹤0.01%
2,489
-1,274
-34% -$12.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.